STOCK TITAN

Atrion Reports Fourth Quarter and Full Year 2022 Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Atrion Corporation (NASDAQ: ATRI) reported strong fourth-quarter and full-year 2022 results. Q4 revenues reached $42.9 million, a 6% increase from $40.3 million in Q4 2021, with operating income rising 12% to $8.8 million. Full-year revenues grew 11% to $183.5 million, while net income increased to $35 million from $33.1 million. The diluted earnings per share for 2022 rose to $19.56 from $18.18. The company noted a slight decline in gross profit margin due to rising costs. Despite challenges, Atrion remains debt-free and is investing in future growth, including a $41 million ERP system and facility expansions.

Positive
  • Q4 2022 revenues increased 6% to $42.9 million.
  • Operating income rose 12% in Q4 2022, reaching $8.8 million.
  • Full-year 2022 revenues grew 11% to $183.5 million.
  • Net income increased to $35 million for the full year.
  • Earnings per share for full year 2022 rose 8% to $19.56.
  • Company remains debt-free while investing in growth.
Negative
  • Gross profit margin decreased to 41% in 2022 from 42% in 2021 due to rising costs.

ALLEN, Texas, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI) today announced its results for the fourth quarter ended December 31, 2022 and the full year 2022.

Revenues for the fourth quarter of 2022 totaled $42.9 million compared to $40.3 million for the same period in 2021. For the quarter ended December 31, 2022, operating income was $8.8 million, up $967 thousand over the comparable 2021 period, and net income was $8.3 million, up $195 thousand over the same period in 2021. Fourth quarter 2022 diluted earnings per share were $4.70 compared to $4.50 for the fourth quarter of 2021. For the full year 2022 compared to the full year 2021, revenues increased to $183.5 million from $165.0 million, net income was $35.0 million versus $33.1 million, and diluted earnings per share were $19.56 compared to $18.18.

Commenting on the results of the quarter and the full year compared to prior year periods, David Battat, President and CEO, stated, “We are very pleased with the results of the quarter when, despite supply disruptions, revenues were up 6% to an all-time record amount for a fourth quarter. For the full year 2022, revenues increased 11%, also to a new record level for the Company.” Mr. Battat continued, “Progressively higher costs for labor and raw materials resulted in a 1% drop in gross profit margin, with 2022 concluding at 41% compared to 42% in 2021. Nevertheless, operating income was up 12% for the just-ended quarter and 10% for the year. Net income was up by 2% in the fourth quarter and 6% for the year, adversely impacted by weaker performance in our investment portfolio. Earnings per share were up 8% for the full year, with fewer outstanding shares following the repurchase of 18,828 shares in the fourth quarter at an average cost per share of $603.19 and total repurchases during the full year of 42,568 shares at an average cost per share of $605.78. We remain debt free, despite investing heavily in our future growth. In addition to our ongoing program of aggressive investment in new products and automation, over the last few years we committed $41 million for a new company-wide ERP system and a significant expansion of our Florida facility to meet anticipated future demand.”

Atrion Corporation develops and manufactures products primarily for medical applications. The Company’s website is www.atrioncorp.com.

Contact:
Jeffery Strickland
Vice President and Chief Financial Officer
(972) 390-9800



ATRION CORPORATION

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)

 Three Months Ended
December 31,
 Twelve Months Ended
December 31,
  2022   2021   2022   2021 
Revenues$42,855  $40,293  $183,506  $165,009 
Cost of goods sold 24,681   22,917   107,602   95,637 
Gross profit 18,174   17,376   75,904   69,372 
Operating expenses 9,369   9,538   36,217   33,330 
Operating income 8,805   7,838   39,687   36,042 
        
Interest and dividend income  349    163    988    843 
Other investment income (loss)  (366)   625    (150)   1,477 
Other income  --    --    92    67 
Income before income taxes 8,788   8,626   40,617   38,429 
Income tax provision  (466)  (499)  (5,609)  (5,374)
Net income $8,322  $8,127  $35,008  $33,055 
        
Income per basic share$4.70  $4.51  $19.59  $18.22 
        
Weighted average basic shares outstanding 1,770   1,801   1,787   1,814 
        
Income per diluted share$4.70  $4.50  $19.56  $18.18 
        
Weighted average diluted shares outstanding 1,771   1,806   1,790   1,818 



ATRION CORPORATION

CONSOLIDATED BALANCE SHEETS
(In thousands)

 Dec. 31, Dec. 31,
ASSETS 2022   2021 
 (Unaudited)  
Current assets:   
Cash and cash equivalents$4,731  $32,264 
Short-term investments 21,152   29,059 
Total cash and short-term investments 25,883   61,323 
Accounts receivable 23,951   21,023 
Inventories 65,793   50,778 
Prepaid expenses and other 3,770   3,447 
Total current assets 119,397   136,571 


Long-term investments
 8,669   19,423 


Property, plant and equipment, net
 123,754   97,972 
Other assets 12,892   13,298 
    
 $264,712  $267,264 
    
LIABILITIES AND STOCKHOLDERS’ EQUITY   
    
Current liabilities 18,098   13,346 
Line of credit --   -- 
Other non-current liabilities 7,073   9,622 
Stockholders’ equity 239,541    244,296  
    
 $264,712  $267,264 


FAQ

What were Atrion's Q4 2022 earnings results?

Atrion reported Q4 2022 revenues of $42.9 million, operating income of $8.8 million, and net income of $8.3 million.

How did Atrion's full-year 2022 performance compare to 2021?

Atrion's full-year 2022 revenues were $183.5 million, a growth of 11% compared to 2021.

What is the diluted earnings per share for Atrion for 2022?

The diluted earnings per share for Atrion in 2022 were $19.56, up from $18.18 in 2021.

Did Atrion face any challenges in 2022?

Yes, Atrion experienced a slight decline in gross profit margin due to progressively higher costs for labor and raw materials.

How is Atrion positioning itself for future growth?

Atrion is investing in a new ERP system and expanding its Florida facility, totaling $41 million in investments.

Atrion Corp

NASDAQ:ATRI

ATRI Rankings

ATRI Latest News

ATRI Stock Data

809.44M
1.35M
23.37%
71.86%
2.53%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
ALLEN